Live
Cytiva (Google News)Cytiva introduces next-gen Biacore 8 series SPR systems for drug discovery - BioSpectrum AsiaQiagenQiagen N.V. stock (NL0012169213): Jefferies trims target while shares edge higher - AD HOC NEWSMedtronicMedtronic Clinical Research Freshers Job 2026 – Apply for The Role - BioTecNikaFritsch GmbHLaboratory Mills Market Growth Outlook to 2035: Automation and Nanomaterials Fuel Demand - News and Statistics - IndexBoxMettler ToledoMettler-Toledo stock (US5926881054): laboratory specialist steadies after earnings-driven volatility - AD HOC NEWS10x Genomics BlogIs 10x Genomics (TXG) Quietly Recasting Its Product-Led Story After a Mixed Q1 Beat? - simplywall.st10x Genomics News10x Genomics Inc Class A Trade Ideas — LS:A2PPQJ - TradingViewEvery GreenThe MLB standings are lying to you with a third of the season gone - FanSidedAbbottAbbott Deepens Digital Health Push With New Cardiovascular Diagnostics And Wearables - simplywall.stEndpoints NewsInside Makary’s ouster; Another win for Lilly’s triple-G; and moreBio-RadIs It Time To Reassess Bio-Rad Laboratories (BIO) After Its Recent 16% Weekly Surge? - simplywall.st10x Genomics BlogSerge Saxonov (TXG) reports multiple 2026 sales and a 35,270-share RSU grant - Stock Titan
BioPharma Dive Apr 9, 2026

Invivyd reveals plans to test an antibody drug against measles

Invivyd reveals plans to test an antibody drug against measles

Original
Body unavailable. Use the original source.